# MiCrobiota-gut-brain Axis in Resistant Epilepsy

> **NCT07010445** · NA · RECRUITING · sponsor: **Niguarda Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Gut Microbiota
- Epilepsy
- Drug-Resistant Epilepsy

## Interventions

- **OTHER:** Naïve: epilepsy first diagnosis,
- **OTHER:** DRE-surgery: resective surgery;
- **DRUG:** anti-epileptic drugs;
- **OTHER:** DRE-VNS: vagal nerve stimulation;
- **OTHER:** DRE-KD: ketogenic diet.

## Key facts

- **NCT ID:** NCT07010445
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-16
- **Primary completion:** 2026-08
- **Final completion:** 2027-02
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07010445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07010445, "MiCrobiota-gut-brain Axis in Resistant Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07010445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*